US
Revvity Sites Globally
Select your location.
*e-commerce not available for this region.
HTRF MAb Anti 6HIS-XL665, 5,000 Assay Points
HTRF MAb Anti 6HIS-XL665, 5,000 Assay Points
MAb Anti 6HIS-XL655
XL665-labeled anti-6His antibody for capturing 6His-tagged proteins in protein/protein interaction assays.
For research use only. Not for use in diagnostic procedures.
| Feature | Specification |
|---|---|
| Application | Protein-Protein Interaction |
XL665-labeled anti-6His antibody for capturing 6His-tagged proteins in protein/protein interaction assays.
For research use only. Not for use in diagnostic procedures.
Product Variants
Unit Size: 1,000 Assay Points
Part #:
61HISXLF
List Price
USD 262.25
Unit Size: 5,000 Assay Points
Part #:
61HISXLA
List Price
USD 609.47
Unit Size: 20,000 Assay Points
Part #:
61HISXLB
List Price
USD 1,911.00
HTRF MAb Anti 6HIS-XL665, 5,000 Assay Points
MAb Anti 6HIS-XL655
HTRF MAb Anti 6HIS-XL665, 5,000 Assay Points
Product information
Overview
MAb Anti-6HIS-XL665 is an IgG2a raised against a polyhistidine tagged fusion protein labeled with XL665. It recognizes synthetic polyhistidine or polyhistidine-tagged fusion protein.
This reagent can be used in both biochemical and cellular formats to study a wide variety of interactions: protein/protein, protein/peptide, protein/DNA, protein/RNA, protein/carbohydrate, protein/small molecule, receptor/ligand.
HTRF can detect a broad range of affinity constants ranging from picomolar to low millimolar.
Specifications
| Application |
Protein-Protein Interaction
|
|---|---|
| Brand |
HTRF
|
| Detection Modality |
HTRF
|
| Product Group |
Fluorescent Reagent
|
| Shipping Conditions |
Shipped Ambient
|
| Target Class |
Binding Assay
|
| Technology |
TR-FRET
|
| Therapeutic Area |
Cardiovascular
Infectious Diseases
Inflammation
Metabolism/Diabetes
NASH/Fibrosis
Neuroscience
Oncology & Inflammation
Rare Diseases
|
| Unit Size |
5,000 Assay Points
|
Video gallery
HTRF MAb Anti 6HIS-XL665, 5,000 Assay Points
HTRF MAb Anti 6HIS-XL665, 5,000 Assay Points
Citations
How it works
Assay principle
In an HTRF interaction assay, one partner is labeled (directly or indirectly) with the donor, and the other with the acceptor (again, directly or indirectly). The intensity of the signal is proportional to the binding of the 2 partners. In the example shown here: MAb Anti 6HIS-XL665 binds to the 6 His tagged partner A while partner B* binds to a specific Ab labeled with an HTRF acceptor. *partner B can also be biotinylated, tagged, Fc fused. In these cases, use the corresponding HTRF reagent (anti-Tag, anti-species, protA, Streptavidin) labeled with acceptor for the detection.
Assay protocol
The example on the right describes the protocol using a 20 µL final assay volume for detecting an interaction between a 6 His-tagged partner A and a non-tagged partner B*. Dispense the 2 partners (10 µL), incubate, add MAb Anti 6HIS-XL665 (5 µL) and anti-partner B labeled with donor (5 µL), incubate and read. *partner B can also be biotinylated, tagged, Fc fused or directly labeled. In these cases, use the corresponding HTRF reagent (anti-Tag, anti species, protA, Streptavidin) labeled with donor for the detection.
Assay details
Build HTRF interaction assays for your specific application
Reagents are sold by the number of tests (20 µL reactions). Antibodies conjugated to XL665 or d2 are supplied on the basis of 20 ng of antibody per well. The amount of active moiety per vial is also provided (as well as the number of tracers per vial - see product description sheet). The active moiety is defined as the active part of a conjugate (e.g. antibody).
How do the number of tests relate to active moiety?
The average conjugate quantity per well reflects overall biological material content. Using the active moiety amount is generally preferred to the quantity of total conjugate. For Cryptate and d2 conjugates, the total conjugate amount equals that of the active moiety, since the molecular weight of the label is negligible. This is not the case for XL665 labeled entities for which the quantity of total conjugate will vary depending on the final molar ratio of the XL665 conjugate, however, the amount of active moiety, provided by Revvity, is constant and based on the number of tests ordered.
Resources
Are you looking for resources, click on the resource type to explore further.
Guide
HTRF solutions, guide to major applications
This guide provides you an overview of HTRF applications in several therapeutic areas.
Flyer
Solutions to advance your CART-T cell research
Chimeric antigen receptor (CAR) T-cell therapy has transformed the field of immuno-oncology providing a novel approach to treating...
SDS, COAs, Manuals and more
Are you looking for technical documents related to the product? We have categorized them in dedicated sections below. Explore now.
Safety data sheet
-
LanguageEnglishCountryUnited States
-
LanguageFrenchCountryFrance
-
LanguageGermanCountryGermany
-
LanguageGreekCountryGreece
-
LanguageItalianCountryItaly
-
LanguageSpanishCountrySpain
-
LanguageEnglishCountryUnited Kingdom
+ Show more
Certificate of analysis
-
Lot number72ARLot dateSeptember 13, 2026
-
Lot number71RALot dateNovember 30, 2025
+ Show more
Technical data sheet
-
Lot number72ARLot dateSeptember 13, 2026
-
Lot number71ALot dateNovember 30, 2025
-
Lot number71RALot dateNovember 30, 2025
-
Lot number70CLot dateAugust 11, 2025
-
Lot number70BLot dateJanuary 4, 2025
+ Show more
IFUs, Manuals & more
-
Resource typeManualLanguageEnglishCountry-
How can we help you?
We are here to answer your questions.
